Girard N, Bar J, Baas P, Chouaid C, Christoph DC, Field JK, Fietkau R, Garassino MC, Garrido Lopez P, Gregorc V, Haakensen VD, Hiltermann TJN, Kao S, McDonald F, Mornex F, Moskovitz M, Peters S, Siva S, Solomon B, Qiao Y, Anand S, Chander P, Shcherbakova T, Diaz Perez I, Filippi AR(2026) Real-world 5-year outcomes with durvalumab after chemoradiotherapy in unresectable stage III NSCLC ESMO Open, 11(2), 106070(in press) DOI 10.1016/j.esmoop.2026.106070, PubMed 41643268
Karlsson K, Rancati T, Lindbäck E, Lindberg S, Grozman V, Al-Jirf K, Lax I, Hoffmann L, Møller DS, Khalil A, Knap MM, Nielsen TB, Land LH, Kristiansen C, Ramberg C, Rogg LV, Hagen RK, Frøland AS, Drugge N, Nyman J, Josipovic M, Persson GF, Olofsson J, Bergström P, Rosenbrand HOet al.(2026) Dose-Volume Predictors of Fatal Bronchopulmonary Bleeding After Stereotactic Body Radiation Therapy of Centrally Located Lung Tumors: An Analysis of the Expanded HILUS Cohort Int J Radiat Oncol Biol Phys(in press) DOI 10.1016/j.ijrobp.2025.12.007, PubMed 41532892
Myhre PL, Helland Å, Myhr KM, Skogås JG, Langø T, Goll R, Vikse J, Fretland SØ(2026) NorTrials drives growth in Norwegian clinical trials Tidsskr Nor Laegeforen, 146(1) DOI 10.4045/tidsskr.25.0685, PubMed 41556676